ARCHIVES

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

This article is from The Cancer Letter archive.

Vol. 22 No. 48 | December 13, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Cells To Be Studied In Space; GrieshaberTo Head Drug Discovery Program

January 30, 1998

Tafinlar Subgroup Data Shows Median OS of 20 Months

October 31, 2014

In Brief: AACR Lectures Listed; Winn Heads Community Oncology At MDA; Henderson ACS Grant Renewed

April 5, 1985

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

December 28, 2012

Intensive Chemo Equivalent To Transplant For MCL

December 26, 2008

Lung Cancer Size May Not Indicate Severity Of Disease

March 29, 2002